Dydrogesterone Versus GnRH Antagonist in Poor Responders Undergoing Double Ovarian Stimulation
ConditionInfertility
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexFemale
Age35-44
SponsorBedaya Hospital
About this trial
The aim of this randomized controlled trial is to compare the efficacy and cost-effectiveness of using progestin with GnRH antagonist to prevent premature LH surge in poor responders undergoing double stimulation protocol.
Eligibility criteria
Qualifiers
None
Disqualifiers
PCOS
Endometriosis
History of recurrent abortion
Trial design
Treatments tested in this trial
- Progestin primed ovarian stimulation
- GnRH antagonist
Treatment groups
120 Participants
are divided into 2 treatment groupsSponsors and collaborators
Bedaya Hospital
Lead sponsor
Cairo University
Collaborator
Source ClinicalTrials.gov